- Home
- VRNA vs HHH Comparison
VRNA vs HHH Comparison
Compare VRNA & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- HHH
- Stock Information
- Founded
- VRNA 2005
- HHH 2010
- Country
- VRNA United Kingdom
- HHH United States
- Employees
- VRNA N/A
- HHH N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- VRNA Health Care
- HHH Real Estate
- Exchange
- VRNA Nasdaq
- HHH Nasdaq
- Market Cap
- VRNA 3.4B
- HHH 3.9B
- IPO Year
- VRNA 2017
- HHH N/A
- Fundamental
- Price
- VRNA $67.96
- HHH $73.20
- Analyst Decision
- VRNA Strong Buy
- HHH Strong Buy
- Analyst Count
- VRNA 7
- HHH 2
- Target Price
- VRNA $57.14
- HHH $82.00
- AVG Volume (30 Days)
- VRNA 1.3M
- HHH 541.6K
- Earning Date
- VRNA 02-27-2025
- HHH 02-26-2025
- Dividend Yield
- VRNA N/A
- HHH 4.78%
- EPS Growth
- VRNA N/A
- HHH N/A
- EPS
- VRNA N/A
- HHH 1.52
- Revenue
- VRNA $5,624,000.00
- HHH $1,195,412,000.00
- Revenue This Year
- VRNA N/A
- HHH $67.07
- Revenue Next Year
- VRNA $571.44
- HHH N/A
- P/E Ratio
- VRNA N/A
- HHH $48.00
- Revenue Growth
- VRNA 1127.95
- HHH 10.91
- 52 Week Low
- VRNA $11.39
- HHH $56.24
- 52 Week High
- VRNA $68.64
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- VRNA 76.88
- HHH 41.81
- Support Level
- VRNA $62.24
- HHH $72.85
- Resistance Level
- VRNA $65.50
- HHH $81.22
- Average True Range (ATR)
- VRNA 2.78
- HHH 1.63
- MACD
- VRNA 0.22
- HHH -0.16
- Stochastic Oscillator
- VRNA 94.86
- HHH 11.88
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments, and Seaport.